SENS:NASDAQSenseonics Holdings, Inc. Analysis
Data as of 2026-09-11 - not real-time
$8.79
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $8.79, Senseonics Holdings, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 80.5%. With RSI at 54.8 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $7.55 up to resistance at $10.15.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 52.4% above where the shares trade now. Revenue is growing at 117.8% on a -225.3% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 106.1%, a beta of 2.27 and a maximum drawdown of 57.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 52.4% above where the shares trade now. Revenue is growing at 117.8% on a -225.3% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 106.1%, a beta of 2.27 and a maximum drawdown of 57.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
Generated second quarter revenue of $14.5 million, an increase of approximately 120% year-over-yearRaising full-year...Strong US growth and record gross margins drive raised guidance, though increased investment costs widen net loss.GERMANTOWN, Md. AP — GERMANTOWN, Md. AP — Senseonics Holdings Inc. SENS on Thursday reported a loss of $36.7...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 6.71
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 6.71
- Analyst targets imply +52.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -225.3%
- Analyst targets imply +52.4% versus the current price
- Negative return on equity of -118.2%
Key Metrics & Analysis
Financial Health
Revenue Growth117.80%
Profit Margin-225.34%
P/E Ratio-4.5
ROE-118.24%
ROA-41.41%
Debt/Equity69.56
P/B Ratio5.1
Op. Cash Flow$-95945000
Free Cash Flow$-59241624
Industry P/E29.6
Technical Analysis
TrendBullish
RSI54.8
Support$7.55
Resistance$10.15
MA 20$9.09
MA 50$6.93
MA 200$6.71
MACDBearish
VolumeDecreasing
Fear & Greed Index90.54
Valuation
Target Price$13.40
Upside/Downside52.45%
GradeFair
TypeGrowth
Risk Assessment
Beta2.27
Volatility106.13%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.